Abstract:Rationale & objective: Cross-sectional studies have reported an association of chronic kidney disease-associated pruritus (CKD-aP) with adverse clinical events and patient-reported outcomes (PROs). We studied the longitudinal associations between changes in CKD-aP and clinical outcomes among patients receiving maintenance hemodialysis. Study design: Prospective cohort study. Setting & participants: 7,976 hemodialysis recipients across 21 countries in phases 4-6 (2009-2018) of the Dialysis Outcomes and Practice Patterns Study (DOPPS) who had 2 CKD-aP assessments approximately 12 months apart. Exposures: Exposure status was based on the assessment of pruritis initially and again approximately 1 year later. Four groups were identified, including those with moderate or more severe pruritis only at the initial assessment (resolved), only at the second assessment (incident), at neither assessment (absent), or at both assessments (persistent). Outcomes: Laboratory values and PROs ascertained at the initial assessment of pruritis and 1 year later. Analytical approach: Linear mixed model to investigate changes in laboratory values and PROs over the 1-year study period across the 4 exposure groups. Results: 51% of patients had moderate to severe CKD-aP symptoms at either assessment (22% at both). The prevalences of depression, restless sleep, and feeling drained increased over the study period (+13%,+10%, and+14%, respectively) among patients with incident pruritus and decreased (-5%, -8%, and -12%, respectively) among patients with resolved pruritus. Minimal changes in PROs over time were observed for the absent and persistent groups. Changes over time in laboratory values (phosphorus, Kt/V) were not detected for either of these groups. Compared with patients with absent CKD-aP, the adjusted HRs for patients with persistent CKD-aP were 1.29 (95% CI, 1.09-1.53) for all-cause mortality, 1.17 (1.07-1.28) for all-cause hospitalization, and 1.48 (1.26-1.74) for cardiovascular events. Limitations: No interim evaluation of CKD-aP symptoms between the 2 assessments; potential selection bias from patients who died or were otherwise lost to follow-up before the second assessment. Conclusions: CKD-aP symptoms are chronic, and these findings highlight the potential value of repeated assessment of this symptom using standardized approaches. Future research should systematically investigate potential causes of CKD-aP and options for its effective treatment. Plain-language summary: Previous research has studied itching and its consequences in hemodialysis recipients only at a single time point. We surveyed 7,976 patients receiving maintenance hemodialysis to assess itching over a period of 1 year. We found that, among those experiencing itching at the initial assessment, more than half had persistent symptoms 1 year later. Those in whom itching developed during follow-up were more likely to experience depression, poor sleep, long recovery times after dialysis, and feeling faint or drained. These patients also rated their quality of life as poorer than those who did not experience itching. These findings emphasize the potential value of clinical detection of itching and the pursuit of effective treatments for patients receiving dialysis experiencing these symptoms.

[Correlation Between Ameliorated Kawashima Itch Scale and Visual Analogue Scale].

Reliability and validity of the Persian version of 5-D itching scale among patients with chronic kidney disease

The Severity, Quality of Life, and Correlated Factors of Chronic Kidney Disease-associated Pruritus between Hemodialysis and Kidney Transplant Patients: A Cross-sectional Study

The factors that are associated with itching in chronic kidney patients and evaluation of itching with the 5d itch scale

Chronic kidney disease-associated pruritus significantly impacts on quality of life of patients on haemodialysis and associates with increased levels of serum calcium and phosphorus

Analysis of factors affecting frequency and intensity of pruritus in maintenaning hemodialysis patients with end stage renal failure

Hydration, barrier of skin and uremic pruritus in patients undergoing hemodialysis: A pilot investigation

Pruritus in Hemodialysis Patients: Longitudinal Associations With Clinical and Patient-Reported Outcomes

Visual Analog Scale Questionnaire to Assess Quality of Life Specific to Each Symptom of the International Prostate Symptom Score

Early clinical observation of supra-hemodiafiltration with endogenous reinfusion in the treatment of uremic pruritus

Difelikefalin improves itch-related sleep disruption in patients undergoing haemodialysis

Exploring content and psychometric validity of newly developed assessment tools for itch and skin pain in atopic dermatitis

Chronic kidney disease-associated pruritus (CKD-aP) is associated with worse quality of life and increased healthcare utilization among dialysis patients

Evaluation of reliability, validity and sensitivity of the Chinese version of pruritus-specific quality of life instrument

Relationship Between Standardized Measures of Chronic Kidney Disease-associated Pruritus Intensity and Health-related Quality of Life Measured with the EQ-5D Questionnaire: A Mapping Study

The relationship between chronic kidney disease–associated pruritus and health-related quality of life: a systematic review

Chronic kidney disease-associated pruritus and quality of life with difelikefalin treatment: a post hoc analysis of phase 3 data using the Skindex-10 questionnaire

Safety and effectiveness of HSK21542 for hemodialysis patients: a multiple ascending dose study

Effects of an ice roller on chronic kidney disease‐associated pruritus in patients receiving haemodialysis

[Itching in dialysis, from the patient's point of view]

Development and preliminary validation of the patient-reported Chronic Itch Burden Scale assessing health-related quality of life in chronic pruritus